Literature DB >> 6743510

Effect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231.

T Sato, K Takusagawa, N Asoo, K Konno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6743510      PMCID： PMC1976920          DOI： 10.1038/bjc.1984.148

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver.

Authors:  M Fukushima; Y Suzuki; Y Toira; I Matsunaga; K Ochi; H Nagano
Journal:  Biochem Biophys Res Commun       Date:  1975-09-16       Impact factor: 3.575

2.  Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine.

Authors:  P F Brumbaugh; M R Haussler
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

3.  Antitumor effect of 1 alpha-hydroxyvitamin D3.

Authors:  T Sato; K Takusagawa; N Asoo; K Konno
Journal:  Tohoku J Exp Med       Date:  1982-12       Impact factor: 1.848

4.  1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.

Authors:  Y Honma; M Hozumi; E Abe; K Konno; M Fukushima; S Hata; Y Nishii; H F DeLuca; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.

Authors:  K Colston; M J Colston; D Feldman
Journal:  Endocrinology       Date:  1981-03       Impact factor: 4.736

6.  Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.

Authors:  R J Frampton; L J Suva; J A Eisman; D M Findlay; G E Moore; J M Moseley; T J Martin
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

7.  Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

Authors:  E Abe; C Miyaura; H Sakagami; M Takeda; K Konno; T Yamazaki; S Yoshiki; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205
  7 in total
  4 in total

1.  1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

Authors:  C M Hansen; T L Frandsen; N Brünner; L Binderup
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

2.  Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies.

Authors:  Robert Wieder; Steven C Novick; Bruce W Hollis; Margarette Bryan; Suzanne M Chanel; Kate Owusu; Danielle Camastra; Tracie Saunders; Lillian Pliner; Jonathan Harrison; Peter Bonate; Tom Williams; Steven Soignet
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

Review 3.  The future of vitamin D analogs.

Authors:  Carlien Leyssens; Lieve Verlinden; Annemieke Verstuyf
Journal:  Front Physiol       Date:  2014-04-03       Impact factor: 4.566

4.  Calcitriol and cancer therapy: A missed opportunity.

Authors:  Donald L Trump
Journal:  Bone Rep       Date:  2018-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.